Email this article The role of thyroid hypofunction in development of metabolic syndrome
- Authors: Demidova TY.1, Galieva OR1, Demidova TY.1, Galieva OR1
-
Affiliations:
- Issue: Vol 81, No 4 (2009)
- Pages: 69-72
- Section: Editorial
- URL: https://ter-arkhiv.ru/0040-3660/article/view/30333
- ID: 30333
Cite item
Full Text
Abstract
Aim. To study the role of hypothyroidism and concomitant obesity in the development of metabolic syndrome (MS).
Material and methods. We examined 60 women suffering from obesity and hypothyroidism (TTH 22.24 ± 4.031). We studied lipid spectrum, carbohydrate metabolism, BP and insulin resistance, fat tissue distribution, exercise tolerance.
Results. According to IDF (2005) criteria the women had: metabolic syndrome (83.4%), newly diagnosed hypothyroidism (95%), decompensated hypothyroidism (90%), subclinical hypothyroidism (65%) after six-month replacement therapy with L-T4 MS symptoms declined.
Conclusion. Abnormally high level of TSH may be a component of metabolic syndrome.
Material and methods. We examined 60 women suffering from obesity and hypothyroidism (TTH 22.24 ± 4.031). We studied lipid spectrum, carbohydrate metabolism, BP and insulin resistance, fat tissue distribution, exercise tolerance.
Results. According to IDF (2005) criteria the women had: metabolic syndrome (83.4%), newly diagnosed hypothyroidism (95%), decompensated hypothyroidism (90%), subclinical hypothyroidism (65%) after six-month replacement therapy with L-T4 MS symptoms declined.
Conclusion. Abnormally high level of TSH may be a component of metabolic syndrome.
Keywords
References
- Biondi B., Palmieri E. A., Lombardi G., Fazio S. Effects of subclinical thyroid dysfunction on the heart. Ann. Intern. Med. 2002; 137(11): 904-914.
- Vanderpump M. P., Tunbridge W. M., French J. M. et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 1996; 6: 155-160.
- Vanderpump M. P., Tunbridge W. M. Epidemiology and prevention of clinical and subclinical hypothyroidism. Thyroid 2002; 12: 839-847.
- Canaris G. J., Manowwitz N. R., Mayor G., Ridgway E. C. Do traditional symptoms of hypothyroidism correlate with biochemical disease? J. of Cen. Intern. Med. 1997; 12: 544-550.
- Diez J. J. Hypothyroidism in patients older than 55 years: an analysis of the etiology and assessment of the effectiveness of therapy. J. Gerontol. 2002; 57(5): 315-320.
- Parle J. V., Franklyn J. A., Cross K. W. et al. Prevalence and follow-up of abnormal thyrotrophin (TSH) concentration in the elderly in the United Kingdom. Clin. Endocrinol. (Oxford) 1991; 34(1): 77-83.
- Canaris G. J., Manowitz N. R., Mayor G., Ridgway E. C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 2000: 160: 526-534.
- Мкртумян А. М., Балаболкин М. И., Забелина В. Д. Структура щитовидной железы и состояние тиреоидного обмена при метаболическом синдроме. В кн.: Всероссийская науч.-практ. конф. "Актуальные проблемы заболеваний щитовидной железы: Тезисы докладов. М., 2000. 98-99.
- Hak A. E., Pols H., Visser T. J. et al. Subclinical hypothyroidism is an independent risk factor for atherosclerosis and myocardial infarction in elderly women: the Rotterdam Study. Ann. Intern. Med. 2000; 132: 270-278.
Supplementary files
